Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2009 | 1 |
2011 | 1 |
2012 | 1 |
2015 | 1 |
2016 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pregnancy under sirolimus-based immunosuppression.
Transplantation. 2006 Feb 27;81(4):636. doi: 10.1097/01.tp.0000188947.56244.7d.
Transplantation. 2006.
PMID: 16495817
No abstract available.
Adverse Events and Discontinuation Rates Associated with Sirolimus Treatment in Adult Renal Transplant Patients in Latin America vs Non-Latin American Countries.
Rial MDC, Tedesco Silva H, Pacheco-Silva A, Cruz J, Torres R, Tortella BJ, Li H, Cornicelli P, Estevez C.
Rial MDC, et al.
Transplant Proc. 2020 Apr;52(3):767-774. doi: 10.1016/j.transproceed.2020.01.040. Epub 2020 Mar 17.
Transplant Proc. 2020.
PMID: 32192743
Item in Clipboard
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.
Pestana JO, Grinyo JM, Vanrenterghem Y, Becker T, Campistol JM, Florman S, Garcia VD, Kamar N, Lang P, Manfro RC, Massari P, Rial MD, Schnitzler MA, Vitko S, Duan T, Block A, Harler MB, Durrbach A.
Pestana JO, et al. Among authors: rial md.
Am J Transplant. 2012 Mar;12(3):630-9. doi: 10.1111/j.1600-6143.2011.03914.x. Epub 2012 Feb 2.
Am J Transplant. 2012.
PMID: 22300431
Free article.
Clinical Trial.
Item in Clipboard
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L, Bunnapradist S, Grinyó JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group.
Rostaing L, et al.
Am J Kidney Dis. 2016 Apr;67(4):648-59. doi: 10.1053/j.ajkd.2015.10.024. Epub 2015 Dec 22.
Am J Kidney Dis. 2016.
PMID: 26717860
Free article.
Clinical Trial.
Item in Clipboard
Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial.
Alberú J, Pascoe MD, Campistol JM, Schena FP, Rial Mdel C, Polinsky M, Neylan JF, Korth-Bradley J, Goldberg-Alberts R, Maller ES; Sirolimus CONVERT Trial Study Group.
Alberú J, et al. Among authors: rial mdel c.
Transplantation. 2011 Aug 15;92(3):303-10. doi: 10.1097/TP.0b013e3182247ae2.
Transplantation. 2011.
PMID: 21792049
Clinical Trial.
Item in Clipboard
Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.
Pescovitz MD, Nezakatgoo N, Lorber MI, Nashan B, Tedesco-Silva H Jr, Kasiske BL, de la Cruz FJ, Russ G, Campistol J, Keown PA; International Sirolimus Study Group.
Pescovitz MD, et al.
Transplantation. 2009 Oct 27;88(8):1010-8. doi: 10.1097/TP.0b013e3181b9d0da.
Transplantation. 2009.
PMID: 19855247
Item in Clipboard
Cite
Cite